Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
08/2012
08/29/2012CN101909619B Composition comprising sesamin component and quercetin glycoside
08/29/2012CN101709251B Bee milk costus and amomum wine
08/29/2012CN101633646B Salts of valsartan
08/29/2012CN101574391B Prevention and treatment of diseases induced by microcirculation disturbance with compatible combination of total salvianolic acid and panax notoginoside
08/29/2012CN101538238B Polymorphs of atorvastatin tert.-butylester and use as intermediates for the preparation of atorvastatin
08/29/2012CN101475524B Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation
08/29/2012CN101472907B Cinnamoyl-piperazine derivatives and their use as PAR-1 antagonists
08/29/2012CN101443344B Trehalose compound and pharmaceutical comprising the compound
08/29/2012CN101108878B Glp-1 analogues
08/28/2012US8252948 Fat composition
08/28/2012US8252929 8-carboxamido-2,6-methano-3-benzazocines
08/28/2012US8252825 Angiotensin II receptor antagonists
08/28/2012US8252818 Nicotinamide derivatives useful as P38 inhibitors
08/28/2012US8252815 Nociceptin analogs
08/28/2012US8252793 Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma
08/28/2012US8252781 1,2-diazetidin-3-one derivatives and drugs containing same
08/28/2012US8252585 Neural progenitor cell populations
08/28/2012US8252524 Method of screening pharmaceutical compositions that promote nuclear transfer of Cdc42 protein
08/28/2012US8252322 Delivery system with increased bioavailability
08/28/2012US8252283 Method for treating vascular disorders
08/28/2012US8252046 Drug-delivery endovascular stent and method for treating restenosis
08/28/2012CA2656079C Cyclic amine compound
08/28/2012CA2639700C New addition salts of angiotensin-converting enzyme inhibitors with no donor acids, a process for their preparation and pharmaceutical compositions containing them
08/28/2012CA2581666C Process for producing concentrate of unsaturated fatty acid
08/28/2012CA2534493C Butenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and use for the treatment of dyslipidaemia, atherosclerosis and diabetes
08/28/2012CA2454073C Mutations in ion channels
08/28/2012CA2445578C Biological pacemaker comprising dominant-negative kir2.1aaa
08/28/2012CA2437812C Compositions and methods for modulation of vascular structure and/or function
08/28/2012CA2432978C Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
08/28/2012CA2389345C Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
08/28/2012CA2387805C Nucleic acids encoding endotheliases, endotheliases and uses thereof
08/23/2012WO2012112742A1 Substituted aminobutyric derivatives as neprilysin inhibitors
08/23/2012WO2012112527A1 Omega 3 formulations comprising epa, dha and dpa for treatment of risk factors for cardiovascular disease
08/23/2012WO2012112517A1 Omega 3 fatty acid diagniostic assay for the dietary management of patients with cardiovascular disease (cvd)
08/23/2012WO2012112511A1 Cholesterol absorption inhibitor (azetidinone) and omega 3 fatty acids (epa, dha, dpa) for the reduction of cholesterol and for the reduction of cardiovascular events
08/23/2012WO2012112007A2 Composition containing inducer of sirt1 expression for preventing or treating sepsis or septic shock
08/23/2012WO2012111795A1 Ameliorating agent for lifestyle-related diseases containing water extract of colored onion
08/23/2012WO2012111643A1 Adiponectin production promoter, and medicinal composition, food, drink and feed containing adiponectin production promoter
08/23/2012WO2012111627A1 Nanoparticle containing prostaglandin i2 derivative
08/23/2012WO2012110599A1 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
08/23/2012WO2012110092A1 Tamsulosin derivatives
08/23/2012WO2012110017A1 Dietetic or pharmaceutical preparation containing tartary buckwheat
08/23/2012WO2012081905A3 Pharmaceutical composite formulation comprising hmg-coa reductase inhibitor and aspirin
08/23/2012WO2012060607A3 Composition for dissolving thrombi, and a pharmaceutical composition for treating stenotic or occlusive vascular diseases which comprises the same
08/23/2012WO2012018791A3 Preparation of prasugrel hydrochloride
08/23/2012US20120214869 Novel ligand activators of the rar receptors and pharmaceutical/cosmetic applications thereof
08/23/2012US20120214858 Imidamide sphingosine kinase inhibitors
08/23/2012US20120214854 Carboxy oxazole or thiazole compounds as dgat- 1 inhibitors useful for the treatment of obesity
08/23/2012US20120214849 Dual-acting antihypertensive agents
08/23/2012US20120214845 Active metabolite of a thrombin receptor antagonist
08/23/2012US20120214840 Indolizine inhibitors of 5-lipoxygenase
08/23/2012US20120214838 THERAPEUTICALLY USEFUL SUBSTITUTED HYDROPYRIDO [3,2,1-ij] QUINOLINE COMPOUNDS
08/23/2012US20120214827 Anhydrous Crystalline Forms of N-[1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-yl-amino)-1H-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide
08/23/2012US20120214819 Use of N--4-(3-pyridyl)-2-pyridine-amine for the Treatment of Pulmonary Hypertension
08/23/2012US20120214818 Methods of treating diastolic dysfunction and related conditions
08/23/2012US20120214817 Urotensin ii receptor antagonists
08/23/2012US20120214815 2-Oxo-1-Pyrrolidine Derivatives, Processes for Preparing Them and Their Uses
08/23/2012US20120214814 Antioxidant inflammation modulators: oleanolic acid derivatives with amino acid and other modifications at c-17
08/23/2012US20120214812 Compounds and compositions as lxr modulators
08/23/2012US20120214807 Compounds useful as antagonists of ccr2
08/23/2012US20120214806 3-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazines
08/23/2012US20120214804 Pharmaceutical composition comprising indole compound
08/23/2012US20120214800 Organic Compounds
08/23/2012US20120214799 Kinase inhibitors
08/23/2012US20120214794 Heteroaryls and uses thereof
08/23/2012US20120214792 Thieno- adn furo-pyrimidine modulators of the histamine h4 receptor
08/23/2012US20120214788 Heteroaryl-substituted piperidines
08/23/2012US20120214787 Oxadiazole inhibitors of leukotriene production
08/23/2012US20120214780 Substituted porphyrins
08/23/2012US20120214771 Compositions for treatment of cardiometabolic disorders
08/23/2012US20120214770 Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors
08/23/2012US20120214769 Novel Antagonists of the Glucagon Receptor
08/23/2012US20120214768 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
08/23/2012US20120214761 Pre-mixed, ready-to-use iv bolus nicardipine compositions and methods of use
08/23/2012US20120214754 Fgf receptor-activating n-acyl octasaccharides, preparation thereof, and therapeutic use thereof
08/23/2012US20120214737 Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by nrg-2
08/23/2012US20120214735 Acetamide derivatives as glucokinase activators, their process and medicinal applications
08/23/2012US20120214734 Treatment of metabolic disorders
08/23/2012US20120214729 Composition for preventing or treating inflammation
08/23/2012US20120214687 Baff receptor (bcma), an immunoregulatory agent
08/23/2012US20120213872 Compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof
08/23/2012US20120213863 Therapeutic gas for the treatment of mitochondrial disorders
08/23/2012US20120213855 Dosage forms for weakly ionizable compounds
08/23/2012US20120213854 Methods of treating a subject and related particles, polymers and compositions
08/23/2012US20120213850 Controlled Release and Taste Masking Oral Pharmaceutical Composition
08/23/2012US20120213839 Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
08/23/2012US20120213838 Medical device for placement into a lumen and manufacturing method thereof
08/23/2012US20120213831 Microspheres for active embolization
08/23/2012US20120213829 Dry powder aerosols of nanoparticulate drugs
08/23/2012US20120213823 Compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof
08/23/2012US20120213807 Neprilysin inhibitors
08/23/2012US20120213806 Neprilysin inhibitors
08/23/2012US20120213791 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
08/23/2012US20120213782 Bmp10 antibodies and related methods
08/23/2012US20120213777 Vascular endothelial growth factor 2
08/23/2012US20120213776 Antibodies to granulocyte-macrophage colony-stimulating factor
08/23/2012US20120213768 Diagnostic and Therapeutic Uses for B Cell Maturation Antigen
08/23/2012US20120213767 Extended Soluble PH20 Polypeptides and uses thereof
08/23/2012US20120213766 Anticancer Compounds from Vernonia Guineensis
08/23/2012US20120213763 Mutants of streptokinase and their covalently modified forms
1 ... 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 ... 1595